Pfizer begins study of Covid jabs updated to match Omicron variant

Pfizer has begun a study comparing its original Covid-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant.
Pfizer and its partner BioNTech announced the study on Tuesday.